Back to NBIX
Swiss Life Asset Management Ltd → NBIX
Swiss Life Asset Management Ltd NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
17
Latest value
$3.2M
Q3 2026
Peak value
$9.8M
First seen
Q4 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2022 | $301K |
| Q1 2023 | $267K |
| Q2 2023 | $427K |
| Q3 2023 | $2.4M |
| Q3 2023 | $490K |
| Q4 2023 | $785K |
| Q2 2024 | $545K |
| Q3 2024 | $420K |
| Q4 2024 | $1.4M |
| Q1 2025 | $1.5M |
| Q1 2025 | $205K |
| Q2 2025 | $1.7M |
| Q3 2025 | $2.5M |
| Q4 2025 | $2.7M |
| Q1 2026 | $2.7M |
| Q2 2026 | $9.8M |
| Q3 2026 | $3.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.2M | 22.4K | — | — |
| Q2 2026 | $9.8M | 58.2K | — | — |
| Q1 2026 | $2.7M | 20.7K | — | — |
| Q4 2025 | $2.7M | 18.7K | — | — |
| Q3 2025 | $2.5M | 17.8K | — | — |
| Q2 2025 | $1.7M | 13.5K | — | — |
| Q1 2025 | $205K | 1.9K | — | — |
| Q1 2025 | $1.5M | 13.1K | — | — |
| Q4 2024 | $1.4M | 10.4K | — | — |
| Q3 2024 | $420K | 3.6K | — | — |
| Q2 2024 | $545K | 4.0K | — | — |
| Q4 2023 | $785K | 6.0K | — | — |
| Q3 2023 | $490K | 4.4K | — | — |
| Q3 2023 | $2.4M | 21.4K | — | — |
| Q2 2023 | $427K | 4.5K | — | — |
| Q1 2023 | $267K | 2.6K | — | — |
| Q4 2022 | $301K | 2.5K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M